Sign In
Buy EXAS
$104.91
+0 (+0%)
At Close: Jun 03, 2026
Here's How Much a $1000 Investment in Exact Sciences Made 10 Years Ago Would Be Worth Today
01:30pm, Monday, 30'th Jan 2023 Zacks Investment Research
Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.
Has Exact Sciences (EXAS) Outpaced Other Medical Stocks This Year?
11:18am, Monday, 30'th Jan 2023
Here is how Exact Sciences (EXAS) and Lantheus Holdings (LNTH) have performed compared to their sector so far this year.
Tracking Cathie Wood's ARK Invest 13F Portfolio - Q4 2022 Update
06:28am, Friday, 27'th Jan 2023 Seeking Alpha
ARK Invest’s 13F portfolio value decreased from $14.35B to $11.54B this quarter. Click here for an ongoing analysis of the changes made to its portfolio on a quarterly basis.
'I Think You Should Take The Money And Run': Cramer On This Stock Up 52% Over Past Month
01:53pm, Wednesday, 25'th Jan 2023 Benzinga
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Amicus Therapeutics Inc (NASDAQ: FOLD) is an "ideal spec."
When asked about QuantumScape Corporation (NYSE: QS), he said, "I think you sho
Better Long-Term Buy in 2023: Exact Sciences or Veracyte?
03:23pm, Tuesday, 24'th Jan 2023 The Motley Fool
As cancer screenings are becoming covered more often, both companies stand to gain.
Cathie Wood Is Trouncing the Market So Far in 2023 Mainly Due to These 3 Stocks
12:55pm, Tuesday, 24'th Jan 2023 The Motley Fool
Wood's ARK Innovation ETF is rebounding nicely.
Better Long-Term Buy in 2023: Exact Sciences or Veracyte?
10:23am, Tuesday, 24'th Jan 2023
As cancer screenings are becoming covered more often, both companies stand to gain.
Exact Sciences (EXAS) Stock Sinks As Market Gains: What You Should Know
11:00pm, Monday, 23'rd Jan 2023 Zacks Investment Research
Exact Sciences (EXAS) closed at $67.82 in the latest trading session, marking a -0.6% move from the prior day.
48.8% of Cathie Wood's Portfolio Is in These 7 Stocks
02:23pm, Monday, 23'rd Jan 2023 The Motley Fool
The popular investment manager is attracted to innovative companies.
Down 40% in 2022, Can Exact Sciences Recover in 2023?
10:43am, Monday, 23'rd Jan 2023 The Motley Fool
Investors are attracted to its leading position in the market for early cancer detection, but the persistent losses its been reporting are enough to make anyone nervous.
48.8% of Cathie Wood's Portfolio Is in These 7 Stocks
09:23am, Monday, 23'rd Jan 2023
The popular investment manager is attracted to innovative companies.
Down 40% in 2022, Can Exact Sciences Recover in 2023?
05:43am, Monday, 23'rd Jan 2023
Investors are attracted to its leading position in the market for early cancer detection, but the persistent losses its been reporting are enough to make anyone nervous.
Investing in Biotech ETFs
04:56pm, Friday, 20'th Jan 2023 The Motley Fool
Here are the five best biotech ETFs to invest in right now.
Cathie Wood Is Crushing It This Year Thanks To 9 Stocks
08:00am, Friday, 20'th Jan 2023
Cathie Wood's ARK Innovation ETF is back — and back big. It's the top diversified ETF again this year so far, largely due to big winners.
Exact Sciences (EXAS) Stock Moves -0.67%: What You Should Know
11:15pm, Wednesday, 18'th Jan 2023 Zacks Investment Research
Exact Sciences (EXAS) closed at $67.92 in the latest trading session, marking a -0.67% move from the prior day.
